Andere Sprachen Gilead Sciences, Inc.

Aktien

885823

US3755581036

GILD

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 28.05.2024			% 5 Tage	% 1. Jan.
63.94 ^USD	-2.65%		-4.98%	-21.07%

15.05.	Transcript : Gilead Sciences, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-15-2024 10:30 AM
14.05.	Transcript : Gilead Sciences, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Nike y otros dos títulos estadounidenses "claramente infravalorados"	27.05.
Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024	22.05.
Gilead Sciences - Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis	20.05.
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis	18.05.
Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy	14.05.
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program	09.05.
Declaration of Voting Results by Gilead Sciences	09.05.
Declaration of Voting Results by Gilead Sciences	09.05.
Declaration of Voting Results by Gilead Sciences	09.05.
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program	09.05.
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates	07.05.
Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024	07.05.
Hoge cashburn Galapagos	03.05.
Aandeelhouders Galapagos keuren alle agendapunten goed	01.05.
Gilead Sciences to Present at Upcoming Investor Conferences	30.04.
Gilead Sciences Receives FDA Approval for Updated Label of Biktarvy	26.04.
Well, it isn't as bad as feared...	26.04.
Alphabet : ExxonMobil, Microsoft...les valeurs à suivre aujourd'hui à Wall Street	26.04.
STATI UNITI. - I titoli da tenere d'occhio a Wall Street	26.04.
EE.UU. - Valores a seguir en Wall Street	26.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Gilead Sciences, Inc.

Aktien

885823

US3755581036

GILD

Andere Sprachen

Filter